Research for molecular mechanisms of lymphangiogenesis and lymph node metastasis
Research for molecular mechanisms of lymphangiogenesis and lymph node metastasis
批准号:
16390378
负责人:
KUBO Hajime
金额:
$9.15万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2004
资助国家:
日本
项目状态:
已结题
起止时间:
2004 至 2005
中文摘要
1.淋巴标志物Podoplan in在肿瘤中的表达与淋巴结转移密切相关,我们建立了新型的抗人Podoplan in抗体,并利用组织芯片技术发现了其在多种癌细胞中的表达。2.同源盒基因PROX1是一个新的肿瘤抑制基因,我们发现PROX1的表达与肿瘤分化程度密切相关。随后,我们还发现PROX1在肿瘤中的低表达与预后不良密切相关。3.两组Thy1阳性的间充质细胞调节肝祖细胞的体外成熟。我们确定粘蛋白跨膜型糖蛋白gp38可以区分立方细胞和Spin…免疫细胞化学显示更多的中间细胞。Gp38阳性细胞促进的肝祖细胞体外成熟可能受到gp38阴性细胞的抑制作用,这可能维持了CD49f阳性细胞的未成熟的增殖状态。4.胚胎干细胞和淋巴管内皮细胞对OP9基质细胞的分化分化第3天由ES细胞分化为LEC的VEGFR-2^+细胞与OP9基质细胞的分化由PROX1、VEGFR-3和另一淋巴标志物podoplan in的表达决定。VEGFR-2^+细胞分化为LYVE-1~+胚胎ECs,第1天PROX1阴性,第3天转为PROX1~+LECs。VEGFR3-Fc或Tie2-Fc,封闭血管内皮生长因子-C或血管生成素1(Ang1),抑制晶状体上皮细胞在OP9细胞上的集落形成。然而,在胶原包被的培养皿中加入血管内皮生长因子-C和血管紧张素1,联合应用于VEGFR-2^+细胞,并不能诱导晶状体上皮细胞。用该条件培养液在PFA固定的OP9细胞上完全复制了OP9细胞的LEC诱导活性。较少
英文摘要
1.The expression of lymphatic marker, podoplanin by cancer were associated with the frequency of lymph node metastasis.We established novel anti-human podoplanin antibodies, and found the expression by several cancer cells using tissue microarrays. We also found that podoplanin was the specific marker for mesothelioma.2.Homeobox gene, prox1 as a novel tumor suppressor gene.We found that there was a significant correlation between prox1 expression and the differentiation scores of the tumors. Subsequently, we also showed that low expression of prox1 in tumors was closely associated with a poor prognosis. The specific knockdown of prox1 by RNA interference strongly accelerated in vitro cell growth, while the over-expression of prox1 greatly suppressed the growth.3.Two populations of Thy1-positive mesenchymal cells regulate the in vitro maturation of hepatic progenitor cellsWe determined that the mucin-type transmembrane glycoprotein gp38 could distinguish the cuboidal cells from the spin … More dle cells by immunocytochemistry. In vitro maturation of hepatic progenitor cells promoted by gp38-positive cells may be opposed by an inhibitory effect of gp38-negative cells, which likely maintain the immature, proliferative state of CD49f-positive cells.4.Differentiation of lymphatic endothelial cells from Embryonic Stem cells on OP9 stromal cellsVEGFR-2^+ cells derived from ES cells differentiated into LECs at day3 on OP9 stromal cells defined by the expression of prox1, VEGFR-3 and another lymphatic marker podoplanin. VEGFR-2^+ cells gave rise to LYVE-1^+ embryonic ECs, which were negative for prox1 on day1 but turned to prox1^+ LECs by day3. VEGFR3-Fc or Tie2-Fc, sequestering VEGF-C or angiopoietin 1 (Ang1), suppressed colony formation of LECs on OP9 cells. However, addition of VEGF-C and Ang1 in combination with VEGF to the culture of VEGFR-2^+ cells on collagen-coated dishes failed to induce LECs. LEC inducing activity of OP9 cells was fully reproduced on PFA-fixed OP9 cells with the conditioned medium. Less
期刊论文(5)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
All-trans retinoic acid modulates proliferation of lung fibroblasts via IL-6/IL-6R system.
全反式维A酸通过IL-6/IL-6R系统调节肺成纤维细胞的增殖。
DOI:
--
发表时间:
2006
期刊:
Am J Physiol Lung Cell Mol Physiol. 290
影响因子:
--
作者:
[Tabata C, Kubo H, Tabata R, Wada M, Sakuma K, Ichikawa M, Fujita S, Mio T, Mishima M]
通讯作者:
Mishima M
DOI:
10.1111/j.1349-7006.2004.tb03211.x
发表时间:
2004-04
期刊:
Cancer Science
影响因子:
5.7
作者:
[K. Shimizu;H. Kubo;K. Yamaguchi;K. Kawashima;Y. Ueda;Koichi Matsuo;M. Awane;Y. Shimahara;]
通讯作者:
K. Shimizu;H. Kubo;K. Yamaguchi;K. Kawashima;Y. Ueda;Koichi Matsuo;M. Awane;Y. Shimahara;
Molecular mechanisms of lymphangiogenesis in diseases.
疾病中淋巴管生成的分子机制。
DOI:
--
发表时间:
2004
期刊:
Microcirculation annual. 20
影响因子:
--
作者:
[Kubo H., Kono T]
通讯作者:
Kono T
DOI:
10.1097/01.pas.0000172192.25295.45
发表时间:
2005-10-01
期刊:
AMERICAN JOURNAL OF SURGICAL PATHOLOGY
影响因子:
5.6
作者:
[Kumasaka, T, Seyama, K, Suda, K]
通讯作者:
Suda, K
Targeting therapy against cancer stem cells
-
批准号:20390341
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$12.31万
-
财政年份:2008
-
负责人:KUBO Hajime
-
依托单位:
Anovel mechanism of tumor progression by the candidate tumor suppressor Proxl : RNA mutation in cancer
-
批准号:18390345
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.28万
-
财政年份:2006
-
负责人:KUBO Hajime
-
依托单位:
Lymphangiogenesis in cancer
-
批准号:17014047
-
项目类别:Grant-in-Aid for Scientific Research on Priority Areas
-
资助金额:$29.06万
-
财政年份:2005
-
负责人:KUBO Hajime
-
依托单位:
海外基金